About
Alexander Pickett is a biotech investor and operator affiliated with longevity-focused investment platforms. He is Managing Director at Juvenescence, where SEC-disclosed biographical information says he oversees new opportunity onboarding, and he is also a Principal at Mediqventures. Earlier, he worked at Flatley Venture Capital and co-founded Real Life Sciences; he also served as Portage Biotech's CEO and director from December 15, 2024 until August 3, 2025, and remained on the board afterward.
Areas of interest
longevitybiotechdrug developmenttherapeuticsregenerative medicineimmuno-oncologyAI drug discoveryclinical trialsmedical devices